ZA201005014B - Method of synthesis of bosentan,its polymorphic forms and its salts - Google Patents

Method of synthesis of bosentan,its polymorphic forms and its salts

Info

Publication number
ZA201005014B
ZA201005014B ZA2010/05014A ZA201005014A ZA201005014B ZA 201005014 B ZA201005014 B ZA 201005014B ZA 2010/05014 A ZA2010/05014 A ZA 2010/05014A ZA 201005014 A ZA201005014 A ZA 201005014A ZA 201005014 B ZA201005014 B ZA 201005014B
Authority
ZA
South Africa
Prior art keywords
bosentan
synthesis
salts
polymorphic forms
polymorphic
Prior art date
Application number
ZA2010/05014A
Other languages
English (en)
Inventor
Ashwini Amol Sawant
Manjinder Singh Phull
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ZA201005014B publication Critical patent/ZA201005014B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA2010/05014A 2008-01-01 2010-07-15 Method of synthesis of bosentan,its polymorphic forms and its salts ZA201005014B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN12MU2008 2008-01-01
IN836MU2008 2008-04-09

Publications (1)

Publication Number Publication Date
ZA201005014B true ZA201005014B (en) 2011-03-30

Family

ID=40424567

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/05014A ZA201005014B (en) 2008-01-01 2010-07-15 Method of synthesis of bosentan,its polymorphic forms and its salts

Country Status (9)

Country Link
US (1) US8481730B2 (enExample)
EP (2) EP2248805A3 (enExample)
JP (1) JP5535082B2 (enExample)
KR (1) KR20100113542A (enExample)
AU (1) AU2009203174B2 (enExample)
CA (1) CA2711043A1 (enExample)
NZ (1) NZ586900A (enExample)
WO (1) WO2009083739A1 (enExample)
ZA (1) ZA201005014B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004287875B2 (en) 2003-11-05 2011-06-02 Bausch + Lomb Ireland Limited Modulators of cellular adhesion
CA2711043A1 (en) 2008-01-01 2009-07-09 Cipla Limited Method of synthesis of bosentan, its polymorphic forms and its salts
US8716477B2 (en) 2009-11-12 2014-05-06 Ranbaxy Laboratories Limited Crystalline forms of bosentan salts and processes for their preparation
JP5356323B2 (ja) * 2010-07-01 2013-12-04 富士化学工業株式会社 新規な非晶質ボセンタン及びその製造方法
WO2012002547A1 (ja) * 2010-07-02 2012-01-05 富士化学工業株式会社 ボセンタン固体分散体
JP5850576B2 (ja) * 2010-07-06 2016-02-03 富士化学工業株式会社 ボセンタン固体分散体
US20130245259A1 (en) 2012-03-16 2013-09-19 Natco Pharma Limited Process for the preparation of bosentan monohydrate
ITMI20120701A1 (it) 2012-04-27 2013-10-28 Dipharma Francis Srl Procedimento per la purificazione di un composto benzensolfonammidico
EP4406950A3 (en) 2012-07-25 2025-04-23 Bausch + Lomb Ireland Limited Lfa-1 inhibitor and polymorph thereof
EP2890694A4 (en) 2012-08-31 2015-12-30 Rao Davuluri Ramamohan 4-TERT-BUTYL-N- [6- (2-HYDROXYETHOXY) -5- (2-METHOXYPHENOXY) -2 (2-PYRIMIDINYL) -PYRIMIDIN-4-YL) -BENZENESULFONAMIDE SODIUM
KR102004422B1 (ko) 2012-12-20 2019-07-26 제일약품주식회사 보센탄 일수화물의 제조방법, 이에 사용되는 신규 중간체 및 이의 제조방법
EP2958914B1 (en) 2013-02-21 2020-07-15 Adverio Pharma GmbH Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
KR102259824B1 (ko) * 2018-07-24 2021-06-02 주식회사 마더스제약 보센탄을 함유한 약학 제제
US20250144095A1 (en) * 2022-02-03 2025-05-08 The Johns Hopkins University Compositions and methods for treatment of connective tissue disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
US6136971A (en) 1998-07-17 2000-10-24 Roche Colorado Corporation Preparation of sulfonamides
MXPA02006660A (es) * 2000-01-07 2002-12-13 Transform Pharmaceuticals Inc Formacion, identificacion y analisis de diversas formas solidas de alto rendimiento.
WO2001055120A1 (en) 2000-01-25 2001-08-02 F. Hoffmann-La Roche Ag Preparation of sulfonamides
US8288401B2 (en) * 2007-05-08 2012-10-16 Generics [Uk] Limited Polymorphic forms
AU2008272685B2 (en) * 2007-06-29 2013-04-18 Generics [Uk] Limited Process for introduction of hydroxyethoxy side chain in bosentan
EP2205591A1 (en) 2007-10-11 2010-07-14 Actavis Group PTC EHF Novel polymorphs of bosentan
JP2011500780A (ja) * 2007-10-24 2011-01-06 ジェネリクス・（ユーケー）・リミテッド 新規結晶形
CA2711043A1 (en) 2008-01-01 2009-07-09 Cipla Limited Method of synthesis of bosentan, its polymorphic forms and its salts
WO2009093127A2 (en) * 2008-01-24 2009-07-30 Actavis Group Ptc Ehf Substantially pure and a stable crystalline form of bosentan
EP2294056A1 (en) * 2008-05-23 2011-03-16 Synthon B.V. Bosentan salts

Also Published As

Publication number Publication date
CA2711043A1 (en) 2009-07-09
EP2248805A3 (en) 2011-02-23
WO2009083739A1 (en) 2009-07-09
AU2009203174A1 (en) 2009-07-09
KR20100113542A (ko) 2010-10-21
EP2248805A2 (en) 2010-11-10
JP5535082B2 (ja) 2014-07-02
EP2238118A1 (en) 2010-10-13
AU2009203174B2 (en) 2014-01-30
US20110015394A1 (en) 2011-01-20
JP2011508767A (ja) 2011-03-17
US8481730B2 (en) 2013-07-09
NZ586900A (en) 2012-10-26

Similar Documents

Publication Publication Date Title
ZA201005014B (en) Method of synthesis of bosentan,its polymorphic forms and its salts
GB0819182D0 (en) Crystalline forms
IL206845A0 (en) Method of synthesizing tetrahydrobiopterin
GB0702854D0 (en) Method for the synthesis of sucrose-6-esters
ZA201105045B (en) Crystalline forms of genistein
EP2212251A4 (en) PROCESS FOR THE PRODUCTION OF CLUSTERBOR
ZA201007125B (en) Isothermal process for phosphoromonochloridite synthesis
EP2233548A4 (en) PROCESS FOR PRODUCING FERROCOKE
ZA201100123B (en) Bromine-facilitated synthesis of fluoro-sulfur compounds
EP2175854A4 (en) IMPROVED METHOD FOR THE SYNTHESIS OF SUBSTITUTED FORMYLAMINES AND SUBSTITUTED AMINES
IL218045A (en) Azididinone compounds, used and production methods
EP2501712A4 (en) PROCESS FOR SYNTHESIS OF AC-ARG-CYCLO- (CYS-D-ALA-HIS-D-PHE-ARG-TRP-CYS-) NH2
GB0701599D0 (en) Method of detection
ZA201105162B (en) Stereoselective synthesis of piperidine derivatives
PL2151430T3 (pl) Nowy sposób wytwarzania krystalicznej postaci V agomelatyny
EP2197859A4 (en) PROCESS FOR PRODUCING BENZOXAZINONE-BASED COMPOUND
EP2514719A4 (en) PROCESS FOR SYNTHESIS OF AMMONIA
EP2205524A4 (en) METHODS OF MANUFACTURING CLUSTER BORON
EP2205525A4 (en) PROCESS FOR THE PREPARATION OF CLUSTERBORON
IL210106A0 (en) Methods of synthesis of morphinans
IL208918A0 (en) Methods of preparing substituted heterocycles-149
SI2341056T1 (sl) Postopek za kristalizacijo eritromicina
GB0813123D0 (en) Method of searching
GB0823366D0 (en) Synthesis
IL212902A0 (en) Method of preparing deoxyribofuranose compounds